2022 -now Venture Partner at 82VS | Alloy Therapeutics Venture Studio @
2021 -2022 Head of Business Development @
2017 -2021 Board Observer @
2017 -2021 Director @
2014 -2017 Senior Manager @
2016 -2021 Board Observer @
2015 -2021 Board Observer @
2013 -2021 Volunteer @ Harvard Community Action Partners
2013 -2014 Blavatnik Fellow in Life Science Entrepreneurship @
2012 -2014 Associate @
2011 -2011 Intern @
2007 -2010 Senior Analyst, BD, Portfolio Analytics, Decision Support, Early Commercial Development @
2006 -2007 Associate @
Ross Leimberg Education
Harvard Business School
Master of Business Administration - MBA
Harvard Business School
BAS, Bioengineering
The Wharton School
BS in Econ, Finance (Finance)
Harvard Business School
MBA, Healthcare (Healthcare)
Harvard Business School
Ross Leimberg Skills
Business Development
Pharmaceutical Industry
Healthcare
Finance
Investments
Portfolio Management
Financial Modeling
Corporate Development
Strategy
Due Diligence
Mergers & Acquisitions
Business Strategy
Biotechnology
Private Equity
Venture Capital
Business Analysis
Leadership
Mergers and Acquisitions
Marketing
Entrepreneurship
Strategic Planning
Management
Public Speaking
Microsoft Office
Ross Leimberg Summary
Ross Leimberg, based in Boston, MA, US, is currently a COO and interim CEO at Cantai Therapeutics. Ross Leimberg brings experience from previous roles at Alloy Therapeutics, Inc., Resilience, Carisma Therapeutics and AbbVie. Ross Leimberg holds a Master of Business Administration - MBA @ Harvard Business School. With a robust skill set that includes Business Development, Pharmaceutical Industry, Healthcare, Finance, Investments and more. Ross Leimberg has 1 emails and 2 mobile phone numbers on RocketReach.
Get contact details of over 700M profiles across 60M companies - all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.